185 related articles for article (PubMed ID: 37303403)
1. A Review of Pityriasis Rosea in Relation to SARS-CoV-2/COVID-19 Infection and Vaccination.
Wong N; Cascardo CA; Mansour M; Qian V; Potts GA
Cureus; 2023 May; 15(5):e38772. PubMed ID: 37303403
[TBL] [Abstract][Full Text] [Related]
2. Pityriasis Rosea after COVID-19 Infection.
Prtajin M; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
[TBL] [Abstract][Full Text] [Related]
3. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
Wang CS; Chen HH; Liu SH
J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
[TBL] [Abstract][Full Text] [Related]
4. Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature.
Veraldi S; Boneschi V; Cusini M; Maronese CA
Dermatol Reports; 2023 Mar; 15(1):9503. PubMed ID: 37063394
[TBL] [Abstract][Full Text] [Related]
5. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
Buckley JE; Landis LN; Rapini RP
JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
[TBL] [Abstract][Full Text] [Related]
6. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
Drago F; Broccolo F; Ciccarese G
Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
[TBL] [Abstract][Full Text] [Related]
7. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
Cohen OG; Clark AK; Milbar H; Tarlow M
Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
[TBL] [Abstract][Full Text] [Related]
8. Pityriasis rosea Gibert triggered by SARS-CoV-2 infection: A case report.
Birlutiu V; Birlutiu RM; Iancu GM
Medicine (Baltimore); 2021 Apr; 100(14):e25352. PubMed ID: 33832113
[TBL] [Abstract][Full Text] [Related]
9. Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection.
Drago F; Broccolo F; Ciccarese G; Rebora A; Parodi A
Dermatology; 2015; 230(1):23-6. PubMed ID: 25612842
[TBL] [Abstract][Full Text] [Related]
10. Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl.
Bin Rubaian NF; Almuhaidib SR; Aljarri SA; Alamri AS
Cureus; 2022 Jul; 14(7):e27108. PubMed ID: 36004038
[TBL] [Abstract][Full Text] [Related]
11. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
Pedrazini MC; da Silva MH
Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
[TBL] [Abstract][Full Text] [Related]
12. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
[TBL] [Abstract][Full Text] [Related]
13. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Valk B; Bender B
Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
[TBL] [Abstract][Full Text] [Related]
14. The clinics of HHV-6 infection in COVID-19 pandemic: Pityriasis rosea and Kawasaki disease.
Dursun R; Temiz SA
Dermatol Ther; 2020 Jul; 33(4):e13730. PubMed ID: 32475003
[TBL] [Abstract][Full Text] [Related]
15. Gestational Pityriasis Rosea: Suggestions for Approaching Affected Pregnant Women.
Monastirli A; Pasmatzi E; Badavanis G; Tsambaos D
Acta Dermatovenerol Croat; 2016 Dec; 24(4):312-313. PubMed ID: 28128088
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
[TBL] [Abstract][Full Text] [Related]
17. Pityriasis Rosea Induced by COVID-19 Vaccination.
Khattab E; Christaki E; Pitsios C
Eur J Case Rep Intern Med; 2022; 9(2):003164. PubMed ID: 35265550
[TBL] [Abstract][Full Text] [Related]
18. Pityriasis Rosea: An Updated Review.
Leung AKC; Lam JM; Leong KF; Hon KL
Curr Pediatr Rev; 2021; 17(3):201-211. PubMed ID: 32964824
[TBL] [Abstract][Full Text] [Related]
19. The role of human herpes virus 6 and 7 in the pathogenesis of pityriasis rosea.
Yildirim M; Aridogan BC; Baysal V; Inaloz HS
Int J Clin Pract; 2004 Feb; 58(2):119-21. PubMed ID: 15055857
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal lesions in pityriasis rosea.
Ciccarese G; Broccolo F; Rebora A; Parodi A; Drago F
J Am Acad Dermatol; 2017 Nov; 77(5):833-837.e4. PubMed ID: 28728872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
